Join the Leukemia group to help and get support from people like you.
Leukemia News (Page 2)
Related terms: Cancer, Leukemia
Weight-Loss Surgery Could Lower Odds for Blood Cancers
MONDAY, Sept. 25, 2023 – Weight-loss surgery can deliver a host of health benefits, but new research reveals an unexpected one: Getting the surgery was associated with a 40% lower risk of blood...
Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
THURSDAY, Aug. 17, 2023 – Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been...
Spleen Volume Linked to Outcome After HSCT for Leukemia Patients
WEDNESDAY, July 19, 2023 – For patients with acute myeloid leukemia (AML), higher spleen volume at the time of hematopoietic stem cell transplant (HSCT) is associated with inferior overall survival...
Overall Incidence Rate of Pediatric Cancer Increased From 2003 to 2019
WEDNESDAY, July 12, 2023 – The overall incidence rate of pediatric cancer increased on average from 2003 to 2019, peaking in 2016, according to a study published online July 11 in the Journal of the...
Overweight/Obese BMI Linked to Worse Survival in Young People With Leukemia
THURSDAY, July 13, 2023 – For adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), overweight/obese body mass index (BMI) is associated with worse outcomes, according to a...
Obesity, Overweight Shrinks Survival Rates Against Childhood Leukemia
WEDNESDAY, July 12, 2023 – A growing obesity epidemic may affect the outcome of treatment for those dealing with cancer, according to a new study of adults and teens being treated for acute...
Allogeneic Hematopoietic Cell Transplant Outcomes Improved From 2005 to 2019
FRIDAY, June 16, 2023 – Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly...
Gas Stove Chemical Tied to Higher Risk of Leukemia
FRIDAY, June 16, 2023 – Using gas stoves can increase indoor air levels of benzene, a chemical linked to higher risk of leukemia and other blood cell cancers, a new study reports. Analysis of dozens...
Risk for Heart Failure Higher in Young Adult Cancer Survivors
WEDNESDAY, June 7, 2023 – Young adult (YA) cancer survivors, especially those diagnosed with leukemia or those treated with anthracycline chemotherapy, face an increased risk for heart failure,...
FDA Medwatch Alert: Drug Safety Communication: Copiktra (duvelisib) - FDA Warns about Possible Increased Risk of Death and Serious Side Effects
ISSUE: The FDA is warning that results from a clinical trial show a possible increased risk of death with Copiktra (duvelisib) compared to another medicine to treat a chronic blood cancer called...
FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia
21 November 2019 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patients with chronic lymphocytic leukemia (CLL) or s...
Agios Announces FDA Approval of Tibsovo as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) – Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the U.S. Food...
FDA Approves Asparlas (calaspargase pegol-mknl) for Acute Lymphoblastic Leukemia (ALL)
On December 20, 2018, the Food and Drug Administration approved calaspargase pegol-mknl (Asparlas, Servier Pharmaceuticals LLC), an asparagine specific enzyme, as a component of a multi-agent...
FDA Medwatch Alert: FDA Warns That Symptoms of a Serious Condition Affecting the Blood Cells Are Not Being Recognized with the Leukemia Medicine Idhifa (enasidenib)
The U.S. Food and Drug Administration (FDA) is warning that signs and symptoms of a life-threatening side effect called differentiation syndrome are not being recognized in patients receiving the...
FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation
November 28, 2018 – The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hairy Cell Leukemia, Blood Disorders